Navigation Links
Comparable data on maternal and infant in Europe available for the first time
Date:12/11/2008

Finland to 4.9 in Latvia and France. The Netherlands and Scotland also had rates of over 4.0 per 1000.
  • Neonatal mortality: Deaths from 0 to 27 days among babies born alive. These ranged from around 2.0 per 1000 live births in Cyprus, Sweden and Norway to 4.6 in Lithuania and 5.7 in Latvia. Countries with rates over 4.0 per 1000 included Estonia, Hungary, Malta, and Poland.
  • Congenital Anomalies: Although the majority of fetuses affected by a congenital anomaly survive the first year of life, congenital anomaly is a major contributor to fetal and neonatal deaths. Perinatal mortality associated with congenital anomaly varies from 0.2 to 2.6 per 1,000 births, and termination of pregnancy for fetal anomaly varies from 0 to 10.7 per 1,000 births
  • Low birthweight: The percentage of live born babies who weighed less than 2500 g. This varied from 4.2 to 4.3% in Estonia, Finland, and Sweden to 8.5% in Greece, 8.3% in Hungary, and 7.4% in Spain. A geographical pattern characterised the incidence of low birthweight in Europe, with lower rates in the more northerly countries.
  • Preterm birth: The percentage of live births occurring before 37 completed weeks of gestation. This rate ranged from 11.4% in Austria and 8.9% in Germany to 5.3% in Lithuania, 5.5% in Ireland 5.6% in Finland 5.7% in Latvia.
  • Maternal mortality ratios: These vary widely, partly because they are based on very small numbers of deaths and partly reflecting differences in health care, which need fuller investigation.
  • Cerebral palsy: which can be associated with adverse perinatal events, affects an estimated one child out of 500. Even when a common definition is used, cerebral palsy rates in Europe vary from 1.04 to 2.50 children with cerebral palsy per 1,000 children born alive.

    • Obstetric practice varies widely in Europe. This raises questions about what level of obstetric intervention is the most appropriate.

    • Rates
      '/>"/>

    Contact: Sverine Ciancia
    severine.ciancia@inserm.fr
    014-423-6086
    INSERM (Institut national de la sant et de la recherche mdicale)
    Source:Eurekalert

    0

    GOOD

    Page: 1 2 3

    Related medicine news :

    1. Prasco to Distribute Generic Forms of Dorzolamide Hydrochloride-Timolol Maleate and Dorzolamide Hydrochloride Ophthalmic Solutions (Comparable to Mercks COSOPT(R) and TRUSOPT(R) Ophthalmic Solutions)
    2. Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
    3. Perforomist-comparable pharmacokinetic and pharmacodynamic profile to DPI formulation
    4. Hospital Care in Singapore Now Available to American Patients at Pre-Negotiated, In-Network Rates Far Lower than Comparable Services in the U.S.
    5. NEJM study demonstrates carotid stenting with embolic protection is comparable to surgery
    6. Iomai Study Shows Self-Applied Travelers Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
    7. Abbotts Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study
    8. Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery
    9. Newborns exposed to maternal smoking more irritable, difficult to soothe
    10. Doc to Dock Completes Maternal Health Wing at Kumasi South Regional Hospital in Ghana
    11. Maternal obesity can program fetal brain to induce adult-onset obesity
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Breaking Medicine News(10 mins):Health News:Researchers Use New Techniques to Assess PTSD 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 4Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 5Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 6Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 7Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 8Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 9Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 10Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 11Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 12Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 13Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 14Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 15Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 16Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 17Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 18Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 19Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 20Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 21Health News:Patient Safety Organization (PSO) Participation: What Every Provider Needs to Know 2Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 2Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 3Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 4Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 5Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 6Health News:Recovery Act dollars are stimulating research at the Medical College of Georgia 2Health News:Recovery Act dollars are stimulating research at the Medical College of Georgia 3
    Breaking Medicine Technology:Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 2Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 3Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 4Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 5Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 6Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 7Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 8Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 9ThromboGenics NV Q3 2009 Business Update 14715 1ThromboGenics NV Q3 2009 Business Update 14715 2ThromboGenics NV Q3 2009 Business Update 14715 3ThromboGenics NV Q3 2009 Business Update 14715 4ThromboGenics NV Q3 2009 Business Update 14715 5ThromboGenics NV Q3 2009 Business Update 14715 6ThromboGenics NV Q3 2009 Business Update 14715 7Development of Batch and Continuous Chemical Processes Using Real Time In Situ FTIR Analytics as a Process Analytical Technology 28PAT 29 Tool 14712 1Development of Batch and Continuous Chemical Processes Using Real Time In Situ FTIR Analytics as a Process Analytical Technology 28PAT 29 Tool 14712 2American Competitive Trail Horse Association Announces Total Health Enhancement Corp as a Sponsor Member 60661 1American Competitive Trail Horse Association Announces Total Health Enhancement Corp as a Sponsor Member 60661 2